48
Participants
Start Date
November 30, 2011
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
Dapivirine Vaginal Ring
dosage form: dapivirine vaginal ring dosage:25 mg frequency:continuous use duration:28 days
Maraviroc Vaginal Ring
dosage form: maraviroc vaginal ring dosage:100 mg frequency:continuous use duration:28 days
Placebo Vaginal Ring
dosage form: placebo vaginal ring dosage:N/A frequency:continuous use duration:28 days
Dapivirine-Maraviroc Vaginal Ring
dosage form: combination vaginal ring dosage:25 mg dapivirine + 100 mg maraviroc frequency:continuous use duration:28 days
Magee-Womens Hospital of UPMC, Pittsburgh
University of Alabama at Birmingham, Birmingham
The Fenway Institute/Fenway Community Health, Boston
International Partnership for Microbicides, Inc.
INDUSTRY